المؤلفون: Zeng YC; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Young OJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Harvard-Massachusetts Institute of Technology (MIT) Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, USA., Wintersinger CM; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Anastassacos FM; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., MacDonald JI; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA., Isinelli G; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Department of Drug and Health Sciences, University of Catania, Catania, Italy., Dellacherie MO; Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA., Sobral M; Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA., Bai H; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA., Graveline AR; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA., Vernet A; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA., Sanchez M; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA., Mulligan K; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Choi Y; Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea., Ferrante TC; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA., Keskin DB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Fell GG; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Neuberg D; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Mooney DJ; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA., Kwon IC; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea.; KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, Republic of Korea., Ryu JH; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. jhryu@kist.re.kr.; Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea. jhryu@kist.re.kr., Shih WM; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. william_shih@dfci.harvard.edu.; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA. william_shih@dfci.harvard.edu.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. william_shih@dfci.harvard.edu.

المصدر: Nature nanotechnology [Nat Nanotechnol] 2024 Mar 15. Date of Electronic Publication: 2024 Mar 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101283273 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1748-3395 (Electronic) Linking ISSN: 17483387 NLM ISO Abbreviation: Nat Nanotechnol Subsets: MEDLINE

المؤلفون: Parvin S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Aryal A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Yin S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Fell GG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA., Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.

المصدر: Blood advances [Blood Adv] 2023 Oct 10; Vol. 7 (19), pp. 5877-5889.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Lymphocytic, Chronic, B-Cell*/pathology, Humans ; Culture Media, Conditioned/pharmacology ; fms-Like Tyrosine Kinase 3/therapeutic use ; Immunoglobulin Variable Region/genetics ; Immunoglobulin Variable Region/therapeutic use ; Signal Transduction ; Tumor Microenvironment

المؤلفون: Fell GG; Data Science, Dana-Farber Cancer Institute, Boston, MA., Nathan DG; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatrics, Harvard Medical School, Boston, MA., Neuberg DS; Data Science, Dana-Farber Cancer Institute, Boston, MA.

المصدر: Blood advances [Blood Adv] 2023 Jul 25; Vol. 7 (14), pp. 3642-3643.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Anemia*/epidemiology , Aging*, Humans

المؤلفون: AlJabban A; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Clinical Investigation, Harvard Medical School, Boston, Massachusetts, USA., Evans MG; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Fell GG; Department of Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Guccione JP; Los Angeles County Department of Medical Examiner-Coroner, Los Angeles, California, USA., Edwards RA; Department of Pathology and Laboratory Medicine, University of California Irvine, Irvine, California, USA., Pinkus GS; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Padera RF; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Pozdnyakova O; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Kim AS; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA Askim@bwh.harvard.edu.

المصدر: Journal of clinical pathology [J Clin Pathol] 2023 Jun 08. Date of Electronic Publication: 2023 Jun 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 0376601 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1472-4146 (Electronic) Linking ISSN: 00219746 NLM ISO Abbreviation: J Clin Pathol Subsets: MEDLINE

المؤلفون: Chen EC; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts., Gandler H; College of Medicine, University of Vermont, Burlington, Vermont., Tošić I; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts., Fell GG; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Fiore A; CRISPR Therapeutics, Cambridge, Massachusetts., Pozdnyakova O; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., DeAngelo DJ; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts., Galinsky I; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts., Luskin MR; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts., Wadleigh M; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts., Winer ES; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts., Leonard R; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts., O'Day K; Bluebird Bio, Cambridge, Massachusetts., de Jonge A; Karyopharm Therapeutics, Boston, Massachusetts., Neuberg D; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Look AT; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Stone RM; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts., Frank DA; Division of Hematology, Winship Cancer Institute of Emory University, Atlanta, Georgia., Garcia JS; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Mar 01; Vol. 29 (5), pp. 878-887.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics, Humans ; Prospective Studies ; Remission Induction ; Protein Kinase Inhibitors/therapeutic use ; Signal Transduction ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

المؤلفون: Sella T; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Harvard University, Boston, MA., Fell GG; Data Science, Dana-Farber Cancer Institute, Boston, MA., Miller PG; Harvard Medical School, Harvard University, Boston, MA.; Center for Cancer Research and Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA., Gibson CJ; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Harvard University, Boston, MA., Rosenberg SM; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY., Snow C; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Stover DG; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Ruddy KJ; Department of Oncology, Mayo Clinic, Rochester, MN., Peppercorn JM; Harvard Medical School, Harvard University, Boston, MA.; Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA., Schapira L; Department of Medicine, Stanford University, Stanford, CA., Borges VF; Division of Medical Oncology, University of Colorado Comprehensive Cancer Center, Aurora, CO., Come SE; Harvard Medical School, Harvard University, Boston, MA.; Division of Oncology, Beth Israel Deaconess Medical Center, Boston, MA., Warner E; Division of Medical Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Frank E; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA., Neuberg DS; Data Science, Dana-Farber Cancer Institute, Boston, MA., Ebert BL; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Harvard University, Boston, MA.; Howard Hughes Medical Institute, Boston, MA., Partridge AH; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Harvard University, Boston, MA.

المصدر: Blood advances [Blood Adv] 2022 Dec 27; Vol. 6 (24), pp. 6151-6161.

نوع المنشور: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Clonal Hematopoiesis* , Hematopoiesis*, Female ; Humans ; Neoplasm Recurrence, Local ; Prospective Studies ; Risk Factors

المؤلفون: Miller PG; Center for Cancer Research and Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA., Fell GG; Department of Data Sciences, Dana Farber Cancer Institute, Boston, MA., Foy BH; Department of Pathology & Center for Systems Biology, Massachusetts General Hospital, Boston, MA.; Department of Systems Biology, Harvard Medical School, Boston, MA., Scherer AK; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA., Gibson CJ; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA., Sperling AS; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA.; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA.; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Burugula BB; Department of Human Genetics, University of Michigan, Ann Arbor, MI., Nakao T; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA.; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA.; Cardiovascular Research Center and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA.; Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Uddin MM; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA.; Cardiovascular Research Center and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA., Warren H; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA., Bry L; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Pozdnyakova O; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Frigault MJ; Center for Cancer Research and Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA., Bick AG; Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Neuberg D; Department of Data Sciences, Dana Farber Cancer Institute, Boston, MA., Higgins JM; Department of Pathology & Center for Systems Biology, Massachusetts General Hospital, Boston, MA.; Department of Systems Biology, Harvard Medical School, Boston, MA., Mansour MK; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA., Natarajan P; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Cardiovascular Research Center and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA., Kim AS; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Kitzman JO; Department of Human Genetics, University of Michigan, Ann Arbor, MI., Ebert BL; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA.; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA.; Howard Hughes Medical Institute, Bethesda, MD.

المصدر: Blood [Blood] 2022 Nov 03; Vol. 140 (18), pp. 1993-1997.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Clonal Hematopoiesis* , COVID-19*, Humans ; Hematopoiesis ; Clonal Evolution ; Mutation

المؤلفون: Harris CK; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Kwong JY; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Cohen MH; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Bland DK; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Fell GG; Department of Statistics, Dana-Farber Cancer Institute, Boston, MA, USA., Nosé V; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Bossuyt V; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

المصدر: American journal of clinical pathology [Am J Clin Pathol] 2022 Jul 01; Vol. 158 (1), pp. 142-147.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0370470 Publication Model: Print Cited Medium: Internet ISSN: 1943-7722 (Electronic) Linking ISSN: 00029173 NLM ISO Abbreviation: Am J Clin Pathol Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/epidemiology , Pathology, Surgical*, Humans ; Pandemics/prevention & control

المؤلفون: Adamia S; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA. sophia_adamia@dfci.harvard.edu., Bhatt S; Dana-FArber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.; Department of Pharmacy, National University of Singapore, Singapore, 117559, Singapore., Wen K; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA., Chyra Z; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA., Fell GG; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Tai YT; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA., Pioso MS; Dana-FArber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA., Abiatari I; Ilia State University, School of Medicine, Tbilisi, G409, Georgia., Letai A; Dana-FArber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA., Dorfman DM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02215, USA., Hideshima T; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA., Anderson KC; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA. kenneth_anderson@dfci.harvard.edu.

المصدر: Leukemia [Leukemia] 2022 Jun; Vol. 36 (6), pp. 1700.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Adamia S; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA. sophia_adamia@dfci.harvard.edu., Bhatt S; Dana-FArber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.; Department of Pharmacy, National University of Singapore, Singapore, 117559, Singapore., Wen K; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA., Chyra Z; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA., Fell GG; Dana-Farber Cancer Institute, Department of Data science, Boston, MA, 02215, USA., Tai YT; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA., Pioso MS; Dana-FArber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA., Abiatari I; Ilia State University, School of Medicine, Tbilisi, G409, Georgia., Letai A; Dana-FArber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA., Dorfman DM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02215, USA., Hideshima T; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA., Anderson KC; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA. kenneth_anderson@dfci.harvard.edu.

المصدر: Leukemia [Leukemia] 2022 Apr; Vol. 36 (4), pp. 1088-1101. Date of Electronic Publication: 2022 Jan 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Multiple Myeloma*/drug therapy, Cyclin-Dependent Kinase 4 ; Cyclin-Dependent Kinase 6 ; Female ; Humans ; Neoplasm Recurrence, Local/drug therapy ; Protein Kinase Inhibitors/therapeutic use